The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases

被引:20
作者
Cofano, Fabio [1 ]
Monticelli, Matteo [1 ]
Ajello, Marco [1 ]
Zenga, Francesco [1 ]
Marengo, Nicola [1 ]
Di Perna, Giuseppe [1 ]
Altieri, Roberto [1 ]
Cassoni, Paola [2 ]
Bertero, Luca [2 ]
Melcarne, Antonio [1 ]
Tartara, Fulvio [3 ]
Ducati, Alessandro [1 ]
Garbossa, Diego [1 ]
机构
[1] Univ Torino, Neurosurg, Dipartimento Neurosci, Turin, Italy
[2] Univ Torino, Pathol, Dipartimento Sci Med, Turin, Italy
[3] Azienda Osped Univ Parma, Special Surg, Neurosurg, Turin, Italy
关键词
bone metastases; breast cancer; cancer; cancer treatment; colorectal cancer; lung cancer; melanoma; NSCLC; renal cancer; lymphoma; RENAL-CELL CARCINOMA; LENALIDOMIDE PLUS DEXAMETHASONE; PROSTATE-SPECIFIC ANTIGEN; NEGATIVE BREAST-CANCER; RANDOMIZED PHASE-II; LUNG-CANCER; DOUBLE-BLIND; OPEN-LABEL; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODY;
D O I
10.1177/1073274819870549
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the last few years, the treatment of spinal metastases has significantly changed. This is due to the advancements in surgical technique, radiotherapy, and chemotherapy which have enriched the multidisciplinary management. Above all, the field of molecular biology of tumors is in continuous and prosperous evolution. In this review, the molecular markers and new approaches that have radically modified the chemotherapeutic strategy of the most common metastatic neoplasms will be examined together with clinical and surgical implications. The experience and skills of several different medical professionals are mandatory: an interdisciplinary oncology team represents the winning strategy in the treatment of patients with spinal metastases
引用
收藏
页数:13
相关论文
共 170 条
[1]  
Adamson RT, 2013, AM J MANAG CARE, V19, pS398
[2]   Combination of nivolumab (nivo) plus ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study. [J].
Andre, Thierry ;
Lonardi, Sara ;
Wong, Ka Yeung Mark ;
Morse, Michael ;
McDermott, Raymond S. ;
Hill, Andrew Graham ;
Hendlisz, Alain ;
Lenz, Heinz-Josef ;
Leach, Joseph W. ;
Moss, Rebecca Anne ;
Cao, Z. Alexander ;
Ledeine, Jean-Marie ;
Chan, Emily ;
Kopetz, Scott ;
Michael, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3]  
[Anonymous], 2018, F1000RES
[4]  
[Anonymous], J CLIN ONCOL
[5]  
[Anonymous], PHAS 3 STUD PEMBR EP
[6]  
[Anonymous], 2016, P AM SOC CLIN S
[7]  
[Anonymous], 2012, BLOOD
[8]  
[Anonymous], 2018, MOL CANC MOL CANC, DOI [10.1186/s12943-017-0753-1, DOI 10.1186/S12943-017-0753-1]
[9]  
[Anonymous], NEW ENGL J MED
[10]  
[Anonymous], CANC CHEMOTHER PHARM